Leadership
Nancy Bradish Myers, JD,
President/Founder
Nancy Bradish Myers, JD, President of Catalyst Healthcare Consulting, Inc., is a Washington-based attorney with deep expertise in health care law and regulation, policy development and government relations. She has been closely involved in cutting edge drug, biotechnology and medtech regulatory issues from a range of vantage points over the past two decades.
Jeff M. Myers, MBA,
Senior Vice President, Market Access & Reimbursement Strategies
Jeff M. Myers, MBA, Senior Vice President, Reimbursement Strategy and Market Access, is an expert advisor helping clients understand and formulate successful market access and reimbursement strategies. His experience spans working for Congress, life science innovators, as well as a range of payors and providers.
Expert Advisor Network
Having the right experts on board impacts whether you get the best answers from regulators. At Catalyst, we pride ourselves on finding the right people with the right expertise to bring into the conversation. We build teams that FDA understands and respects.
Our Expert Advisor Network includes:
- Former FDA Division and Office heads
- Scientific experts (former FDA), including in:
- Genomics/genetics
- Personalized Medicine
- Neurology/diseases related to aging
- Clinical Pharmacology and Pharmacometrics
- International regulatory/harmonization experts (former FDA)
- Patient advocacy experts
- Reimbursement experts
Kelli Malott,
Research Associate and Editor
Kelli Malott, PhD Candidate and Research Associate and Editor at Catalyst Healthcare Consulting, Inc. is a policy savvy toxicologist with extensive experience in biomedical research in the fields of reproductive biology, immunology, oncology, aging, and metabolism.
Ginny Hanlon,
Business Manager & Research Assistant
Ms. Hanlon, Business Manager & Research Assistant at Catalyst Healthcare Consulting, Inc., brings an extensive background in business administration. For ten years, she worked as Senior Administrative Assistant at Eli Lilly and Company in the US Regulatory Division, and prior to that she worked for the President of NABI Biomedical Research.